Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Margie E. Boccieri"'
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease
Autor:
Arthur J, Kastl, Kimberly N, Weaver, Xian, Zhang, Jennifer A, Strople, Jeremy, Adler, Marla C, Dubinsky, Athos, Bousvaros, Runa, Watkins, Xiangfeng, Dai, Wenli, Chen, Raymond K, Cross, Peter D R, Higgins, Ryan C, Ungaro, Meenakshi, Bewtra, Emanuelle A, Bellaguarda, Francis A, Farraye, Kelly Y, Chun, Michael, Zikry, Manory, Fernando, Monique, Bastidas, Cristian G, Hernandez, Riley G, Craig, Margie E, Boccieri, Anne, Firestine, Millie D, Long, Michael D, Kappelman
Publikováno v:
American Journal of Gastroenterology. 118:129-137
Children with inflammatory bowel disease (IBD) may respond differently to COVID-19 immunization as compared with healthy children or adults with IBD. Those younger than 12 years receive a lower vaccine dose than adults. We sought to describe the safe
Autor:
Michael D. Kappelman, David A. Wohl, Hans H. Herfarth, Ann M. Firestine, Jeremy Adler, Rana F. Ammoury, Jeanine E. Aronow, Dorsey M. Bass, Julie A. Bass, Keith Benkov, Catalina Berenblum Tobi, Margie E. Boccieri, Brendan M. Boyle, William B. Brinkman, Jose M. Cabera, Kelly Chun, Richard B. Colletti, Cassandra M. Dodds, Jill M. Dorsey, Dawn R. Ebach, Edurne Entrena, Christopher B. Forrest, Joseph A. Galanko, John E. Grunow, Ajay S. Gulati, Anastasia Ivanova, Traci W. Jester, Jess L. Kaplan, Subra Kugathasan, Mark E. Kusek, Ian H. Leibowitz, Tiffany M. Linville, Ellen A. Lipstein, Peter A. Margolis, Phillip Minar, Zarela Molle-Rios, Jonathan Moses, Kelly K. Olano, Lourdes Osaba, Pablo J. Palomo, Helen Pappa, K.T. Park, Dinesh S. Pashankar, Lisa Pitch, Michelle Robinson, Charles M. Samson, Kelly C. Sandberg, Julia R. Schuchard, Michael Seid, Kimberly A. Shelly, Steven J. Steiner, Jennifer A. Strople, Jillian S. Sullivan, Jeanne Tung, Prateek Wali, Michael Zikry, Morris Weinberger, Shehzad A. Saeed, Athos Bousvaros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0c20a41033da7f74265ab90ee62a011
https://doi.org/10.2139/ssrn.4352561
https://doi.org/10.2139/ssrn.4352561
Autor:
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A Strople, Raymond K Cross, Peter D R Higgins, Ryan C Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A Farraye, Margie E Boccieri, Ann Firestine, Michael D Kappelman, Millie D Long
Publikováno v:
Inflammatory Bowel Diseases. 28:1497-1505
Background Severe acute respiratory syndrome coronavirus 2 vaccination is recommended for all individuals with inflammatory bowel disease (IBD), including those on immunosuppressive therapies; however, little is known about vaccine safety and efficac
Autor:
Kimberly N Weaver, Xian Zhang, Xiangfeng Dai, Wenli Chen, Runa Watkins, Jeremy Adler, Marla C Dubinsky, Arthur Kastl, Athos Bousvaros, Jennifer A Strople, Raymond K Cross, Peter D R Higgins, Ryan C Ungaro, Meenakshi Bewtra, Emanuelle Bellaguarda, Francis A Farraye, Riley Craig, Cristian Hernandez, Margie E Boccieri, Ann Firestine, Kelly Y Chun, Millie D Long, Michael D Kappelman
Publikováno v:
Inflammatory bowel diseases.
Lay Summary We demonstrate low rates of breakthrough coronavirus disease 2019 (COVID-19) infection and mild course of illness following severe acute respiratory syndrome coronavirus 2 vaccination in a large cohort of inflammatory bowel disease patien
Autor:
Michael D. Kappelman, Kimberly N. Weaver, Xian Zhang, Xiangfeng Dai, Runa Watkins, Jeremy Adler, Marla C. Dubinsky, Arthur Kastl, Athos Bousvaros, Jenifer A. Strople, Raymond K. Cross, Peter D.R. Higgins, Ryan C. Ungaro, Meenakshi Bewtra, Emanuelle A. Bellaguarda, Francis A. Farraye, Margie E. Boccieri, A. Firestine, Kelly Y. Chun, Manory Fernando, Monique Bastidas, Michael Zikry, Millie D. Long
Publikováno v:
The American journal of gastroenterology. 117(3)
Although an additional coronavirus disease 2019 vaccine dose for immunocompromised persons has been recommended in some countries, further data to guide vaccination strategies for patients with inflammatory bowel disease (IBD) are urgently needed. We